Home / Articles / Meet the mobile therapy startup backed by Christian Angermayer’s re:Mind Capital

Meet the mobile therapy startup backed by Christian Angermayer’s re:Mind Capital

Mental health startup Ksana Health has received $2 million in seed funding led by re:Mind Capital, the mental health VC arm of Christian Angermayer and Apeiron Investment Group. It’s a move informed by two trends: passive data collection, and a burgeoning mental health crisis in teens and young adu…

  • Posted on 31st Aug, 2021 08:49 AM
  • 1115 Views
Meet the mobile therapy startup backed by Christian Angermayer’s re:Mind Capital Image

Mental health startup Ksana Health has received $2 million in seed funding led by re:Mind Capital, the mental health VC arm of Christian Angermayer and Apeiron Investment Group. It’s a move informed by two trends: passive data collection, and a burgeoning mental health crisis in teens and young adults. 

Ksana Health is an Oregon-based company founded two years ago by University of Oregon Professor Nicholas Allen, a clinical psychologist and director of the Center for Digital Mental Health. Ksana’s platforms focus on collecting data related to mental health, and transfer that data from user to healthcare practitioners through an app. It’s, in essence, a mobile therapy app with a highly detailed dashboard of patient information. 

The company has 12 employees, and other investors in the round include WPSS Investments, Panoramic Ventures, the Telosity Fund, Palo Santo Venture Fund and Able Partners. 

So far, Ksana Health has one live product called the Effortless Assessment Research System (EARS), which is designed for institutions conducting clinical research. Participants in clinical trials can download an app and opt-in to sharing with the trial’s investigators data, including movement, location (via GPS), keystrokes and patterns in written language content (no specific messages are shared). The app’s connection also goes two ways: trial administrators can send out things like surveys to keep in touch with participants. 

The EARS product, says Allen, has already generated about $900,000 in revenue based on usage in clinical trials, but this most recent round of funding is geared toward another product called Vira, aimed at consumers. 

Vira will also passively collect data like exercise (via an accelerometer), screen time, keystrokes or location-based data via a smartphone or smart device. Screenshots from Vira’s dashboard also include sleep data, though that’s not specifically listed as a recorded variable on the company’s website at the moment. Instead of funneling that data to a clinical trial, the data will be accessible to a patient’s therapist. 

Meet the mobile therapy startup backed by Christian Angermayer’s re:Mind Capital View Story

Latest 20 Post